I think its due to muscle loss from Ozempic.
Hypoglycaemia risk is generally low with GLP-1 agonists when used as monotherapy, as their glucose-lowering effect is glucose-dependent
Anti-Aging and Longevity Support As we age, GH and IGF-1 levels naturally decline
Enhancing Your Journey with Personalized Support At TrimRx, we believe that medication is just one piece of the puzzle
But during perimenopause and menopause, several critical pathways slow down: Growth hormone (GH) production declines affecting muscle mass, fat metabolism, skin quality, and recovery Inflammatory markers increase contributing to joint pain, brain fog, and metabolic dysfunction Sleep architecture degrades less deep sleep means less cellular repair, less growth hormone release, and more fatigue Collagen synthesis drops dramatically women lose roughly 30% of their collagen in the first five years of menopause, accelerating skin aging, joint stiffness, and connective tissue weakness Gut lining integrity weakens leading to increased inflammation, food sensitivities, and nutrient malabsorption Sexual function changes declining hormones reduce libido, arousal, and tissue health Peptide therapy doesnt replace what menopause takes away it reactivates the pathways that menopause suppresses
